MarketCapExport financials
Herbalife Nutrition Ltd. (HLF)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Herbalife Nutrition Ltd. Financial Ratios 2025-2007 | HLF
Brief overview of Herbalife Nutrition Ltd.'s valuation multiples
Current figures are compared with the company's own five-year history for 2021–2025.
The current valuation set is P/E 7.36x (median 7.36x), EV/EBITDA 7.68x (median 7.86x), P/S 0.33x (median 0.33x). The combined ratio level is close to the company's five-year norm at a +1.8% deviation. No clear premium or discount is visible.
The inverse P/E implies an earnings yield of 13.6%. This is not a dividend yield, but current earnings relative to market price.
Returns on assets and capital are represented by ROE -44.3%, ROA 8.2%, ROCE -93.4%. Current return ratios are negative, materially weakening the fundamental profile.
On PEG (1.95x), valuation is stretched relative to growth and requires strong execution.
The cash conversion cycle is 139.7 days versus 136.7 days initially. Turnover changed little.
Overall assessment
Herbalife Nutrition Ltd.'s profile looks neutral, with price and fundamental efficiency broadly aligned.
Annual Financial Ratios Herbalife Nutrition Ltd.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
7.4 | 2.2 | 8.2 | 5.3 | 8.4 | 15.9 | 17.5 | 27.8 | 30.7 | 17.8 | 11.3 | 8.5 | 12.6 | 8.7 | 16.3 | 4.5 | 4.5 | 2.8 | - |
P/S |
0.3 | 0.1 | 0.2 | 0.3 | 0.6 | 1.1 | 1.1 | 1.7 | 1.5 | 1.0 | 0.9 | 0.5 | 1.4 | 1.0 | 1.9 | - | - | - | - |
EPS |
2.2 | 2.5 | 1.4 | 3.3 | 4.2 | 2.8 | 2.3 | 2.1 | 1.4 | 1.6 | 4.1 | 3.6 | 5.1 | 4.1 | 3.5 | 2.5 | 1.7 | 3.5 | - |
EV (Enterprise Value) |
4.62 B | 3.68 B | 4.46 B | 5.19 B | 7.37 B | 8.79 B | 7.66 B | 10.6 B | 8.52 B | 6.15 B | 5.46 B | 4.69 B | 7.6 B | 5.12 B | 7.33 B | 1.88 B | 1.56 B | 470 M | -187 M |
EBITDA per Share |
5.86 | 5.04 | 4.74 | 6.71 | 7.95 | 5.63 | 4.85 | 5.59 | 4.53 | 3.35 | 4.13 | 3.52 | 4 | 3.27 | 7.54 | 3.83 | 2.93 | 5.97 | - |
EV/EBITDA |
7.7 | 7.3 | 9.5 | 7.9 | 8.7 | 1.9 | 9.6 | 12.1 | 10.5 | 9.4 | 6.7 | 6.3 | 8.1 | 5.9 | 3.8 | 4.1 | 4.3 | 1.2 | - |
PEG |
1.95 | 0.6 | -47.97 | 0.51 | 0.41 | 1.86 | 2.64 | 0.49 | -2.24 | -0.75 | 0.76 | -0.28 | 0.6 | 0.41 | 0.37 | - | - | - | - |
P/B |
-3.3 | -0.7 | -1.1 | -1.3 | -2.7 | -6.9 | -13.9 | -11.4 | -19.6 | 23.5 | -71.3 | -7.9 | 12.1 | 9.9 | 12.0 | 2.7 | 2.6 | - | - |
P/CF |
5.0 | 2.0 | 3.3 | 4.8 | 8.2 | 9.4 | 15.4 | 14.6 | 13.3 | 20.6 | 6.9 | 7.8 | 10.6 | 9.3 | 16.0 | 3.4 | 3.2 | 2.3 | - |
ROE % |
-44.32 | -31.74 | -13.41 | -25.38 | -32.14 | -43.52 | -79.74 | -41.00 | -63.91 | 132.45 | -633.83 | -92.31 | 95.66 | 113.41 | 73.65 | 61.79 | 57.90 | 91.50 | - |
ROA % |
8.19 | 9.32 | 5.06 | 11.76 | 15.86 | 12.11 | 11.61 | 10.63 | 7.39 | 10.13 | 13.68 | 13.00 | 21.33 | 28.01 | 28.53 | 23.77 | 17.74 | - | - |
ROCE % |
-93.38 | -48.17 | -33.61 | -43.07 | -52.76 | -74.83 | 33.14 | 56.88 | 31.04 | 25.82 | 40.15 | 34.23 | 47.39 | 67.01 | 189.39 | 81.75 | 84.29 | 137.45 | - |
Current Ratio |
0.8 | 0.8 | 0.7 | 0.7 | 0.7 | 0.8 | 1.5 | 1.1 | 2.1 | 1.8 | 1.5 | 1.6 | 1.8 | 1.3 | 1.4 | 1.7 | 1.5 | - | - |
DSO |
5.8 | 5.5 | 5.5 | 4.8 | 4.7 | 5.4 | 6.0 | 5.3 | 7.7 | 5.7 | 5.7 | 6.2 | 7.6 | 10.4 | 9.5 | - | - | - | - |
DIO |
161.6 | 162.1 | 166.4 | 179.8 | 158.6 | 148.7 | 166.2 | 151.6 | 146.8 | 158.6 | 141.6 | 140.3 | 133.1 | 152.5 | 132.9 | 107.3 | 54.0 | - | - |
DPO |
27.8 | 25.5 | 26.6 | 28.3 | 26.6 | 27.0 | 31.1 | 32.2 | 29.2 | 28.2 | 30.3 | 26.9 | 31.3 | 33.8 | 30.6 | 26.5 | 13.8 | - | - |
Operating Cycle |
167.4 | 167.5 | 171.9 | 184.7 | 163.3 | 154.1 | 172.2 | 156.9 | 154.4 | 164.3 | 147.3 | 146.4 | 140.6 | 162.9 | 142.4 | 107.3 | 54.0 | - | - |
Cash Conversion Cycle |
139.7 | 142.1 | 145.2 | 156.4 | 136.7 | 127.1 | 141.1 | 124.7 | 125.3 | 136.1 | 117.0 | 119.5 | 109.3 | 129.1 | 111.8 | 80.8 | 40.2 | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Financial Ratios Herbalife Nutrition Ltd.
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.25 | 0.6 | 0.42 | 0.48 | 0.5 | - | 0.47 | 0.05 | 0.24 | - | 0.43 | 0.6 | 0.3 | - | 0.84 | 0.88 | 0.98 | - | 1.11 | 1.33 | 1.36 | 0.61 | 1.07 | 0.84 | 0.33 | 0.41 | 0.59 | 0.56 | 0.7 | 0.36 | 0.52 | 0.66 | 0.57 | -0.43 | 0.34 | 0.84 | 0.51 | 1.19 | 1.06 | -0.28 | 1.16 | 1.02 | 1.13 | 1 | 0.95 | 1.26 | 0.14 | 1.39 | 0.78 | 1.22 | 1.39 | 1.39 | 1.14 | 1.04 | 4.13 | 4.13 | 0.93 | 0.95 | 0.92 | 0.91 | 0.75 | 1.28 | 1.38 |
EBITDA per Share |
1.81 | 1.62 | - | - | 1.51 | - | - | - | 1.01 | - | - | - | 1 | - | 2.39 | 1.59 | 1.82 | - | 2.55 | 2.2 | 2.3 | - | 2.18 | 1.74 | 0.87 | - | 1.58 | 1.47 | 1.37 | - | 1.93 | 1.7 | 1.25 | - | 1.21 | 1.56 | 2.03 | - | 2.7 | 0.34 | 2.32 | - | 2.84 | 2.32 | 1.93 | - | 1.18 | 2.8 | 1.56 | - | 2.5 | 2.28 | 1.82 | - | 1.99 | 1.92 | 1.49 | - | 1.76 | 1.6 | 1.2 | 2.58 | 2.53 |
ROE % |
-23.00 | -35.39 | -26.34 | -19.73 | -14.61 | -7.76 | -11.64 | -11.88 | -13.83 | -11.48 | -17.52 | -19.75 | -21.30 | -18.90 | -27.71 | -32.84 | -37.55 | -30.79 | -39.41 | -46.74 | -49.02 | -43.52 | -49.44 | -54.21 | -60.38 | -79.74 | -71.96 | -60.91 | -54.34 | -41.00 | -15.30 | -21.74 | -49.80 | -63.91 | -32.21 | 28.75 | 58.19 | 132.45 | -76.13 | -295.76 | -438.86 | -633.83 | -506.78 | -335.20 | -216.17 | -92.31 | -39.03 | -9.90 | 51.79 | 95.66 | 101.63 | 193.20 | 284.56 | 290.28 | 282.00 | 183.87 | 85.94 | 74.51 | 70.87 | 72.47 | 15.85 | 16.44 | 20.79 |
ROA % |
4.64 | 7.43 | 7.07 | 5.65 | 4.76 | 2.88 | 4.46 | 4.83 | 5.74 | 4.82 | 7.84 | 9.75 | 11.70 | 10.61 | 15.47 | 12.45 | 17.98 | 14.50 | 16.90 | 17.28 | 16.16 | 12.11 | 11.83 | 10.38 | 9.50 | 11.61 | 11.25 | 10.76 | 11.28 | 10.63 | 6.69 | 6.02 | 7.39 | 7.39 | 13.45 | 14.99 | 9.34 | 10.13 | 9.67 | 10.03 | 14.26 | 13.68 | 14.66 | 11.36 | 13.05 | 13.04 | 13.64 | 18.91 | 19.66 | 21.32 | 22.84 | 44.01 | 65.13 | 66.59 | 67.60 | 48.13 | 28.73 | 28.61 | 27.15 | 26.56 | 6.14 | 6.07 | 6.84 |
ROCE % |
-99.02 | -88.66 | -70.64 | -57.83 | -44.69 | -28.01 | -37.68 | -35.08 | -33.10 | -26.16 | -36.98 | -38.32 | -38.13 | -32.37 | -46.57 | -54.17 | -59.50 | -48.96 | -73.13 | -81.08 | -73.83 | -57.49 | -94.31 | -109.40 | -129.04 | -117.87 | -143.76 | -133.46 | -115.74 | -73.94 | -109.59 | -144.91 | -161.36 | -139.83 | -62.65 | -37.14 | 109.81 | 152.78 | -149.28 | -495.24 | -738.56 | -824.30 | -832.55 | -589.20 | -358.54 | -105.08 | -70.24 | -27.10 | 62.23 | 100.36 | 141.03 | 153.39 | 157.48 | 126.85 | 153.86 | 140.54 | 115.36 | 76.39 | 98.31 | 100.81 | 22.03 | 21.92 | 29.52 |
Current Ratio |
0.9 | 0.9 | 0.8 | 0.8 | 0.8 | 0.8 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | - | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.8 | 0.8 | 0.8 | 0.8 | 0.9 | 0.9 | 0.9 | 0.9 | 0.8 | 0.8 | 0.8 | 0.8 | 0.9 | 0.9 | 0.9 | 0.9 | 1.1 | 1.1 | 1.1 | 1.1 | 1.0 | 1.0 | 1.0 | 1.0 | 0.9 | 0.9 | 0.9 | 0.9 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.5 |
DSO |
7.6 | 7.1 | 7.0 | 6.8 | 5.9 | - | 6.1 | 6.1 | 6.1 | - | 5.9 | 6.0 | 5.7 | - | 3.0 | 2.8 | 5.2 | - | 6.2 | 6.1 | 5.6 | 5.4 | 5.0 | 5.6 | 5.9 | 6.0 | 5.8 | 5.9 | 5.8 | 5.4 | 5.2 | 5.0 | 6.3 | 7.8 | 7.8 | 7.4 | 6.8 | 6.1 | 5.7 | 5.3 | 5.7 | 5.8 | 5.8 | 5.5 | 6.3 | 6.7 | 6.1 | 5.8 | 6.7 | 7.2 | 7.5 | 7.5 | 8.8 | 10.0 | 10.4 | 10.3 | 9.7 | 9.2 | 9.1 | 9.3 | 10.4 | - | - |
DIO |
154.3 | 157.8 | 164.7 | 164.9 | 165.7 | - | 169.1 | 158.4 | 161.2 | - | 153.8 | 161.9 | 172.0 | - | 85.9 | 82.3 | 170.2 | - | 164.2 | 147.9 | 146.7 | - | 141.8 | 167.7 | 174.1 | - | 163.5 | 163.7 | 154.5 | - | 159.7 | 148.0 | 137.5 | - | 144.5 | 142.3 | 158.9 | - | 162.0 | 143.4 | 150.6 | - | 146.4 | 132.1 | 150.3 | - | 135.2 | 134.0 | 132.4 | - | 134.4 | 129.6 | 139.4 | - | 153.6 | 152.0 | 136.6 | - | 128.9 | 132.2 | 120.8 | 114.8 | - |
DPO |
29.2 | 27.6 | 28.9 | 29.2 | 26.7 | - | 28.5 | 27.6 | 27.8 | - | 25.1 | 23.7 | 24.1 | - | 13.5 | 13.1 | 27.1 | - | 30.5 | 30.6 | 29.0 | - | 25.1 | 29.7 | 31.6 | - | 30.6 | 30.6 | 30.7 | - | 33.9 | 31.4 | 28.3 | - | 28.7 | 28.3 | 29.8 | - | 28.8 | 25.5 | 29.4 | - | 31.4 | 28.3 | 30.4 | - | 25.9 | 25.7 | 28.2 | - | 31.6 | 30.5 | 31.9 | - | 34.0 | 33.7 | 30.8 | - | 29.7 | 30.5 | 30.0 | 33.7 | - |
Operating Cycle |
- | - | 171.6 | 171.7 | 171.7 | - | 175.2 | 164.4 | 167.3 | - | 159.7 | 167.8 | 177.7 | - | 88.9 | 85.1 | 175.4 | - | 170.3 | 154.0 | 152.3 | 5.4 | 146.8 | 173.4 | 180.0 | 6.0 | 169.4 | 169.5 | 160.3 | 5.4 | 164.9 | 153.0 | 143.8 | 7.8 | 152.4 | 149.7 | 165.7 | 6.1 | 167.8 | 148.7 | 156.3 | 5.8 | 152.2 | 137.6 | 156.7 | 6.7 | 141.2 | 139.8 | 139.0 | 7.2 | 142.0 | 137.1 | 148.2 | 10.0 | 164.1 | 162.3 | 146.3 | 9.2 | 138.1 | 141.5 | - | - | - |
Cash Conversion Cycle |
- | - | 142.7 | 142.5 | 144.9 | - | 146.7 | 136.8 | 139.5 | - | 134.6 | 144.2 | 153.6 | - | 75.4 | 72.0 | 148.3 | - | 139.8 | 123.5 | 123.3 | 5.4 | 121.7 | 143.7 | 148.4 | 6.0 | 138.8 | 138.9 | 129.6 | 5.4 | 131.0 | 121.6 | 115.5 | 7.8 | 123.7 | 121.4 | 135.8 | 6.1 | 138.9 | 123.2 | 126.9 | 5.8 | 120.8 | 109.3 | 126.3 | 6.7 | 115.3 | 114.2 | 110.9 | 7.2 | 110.3 | 106.6 | 116.4 | 10.0 | 130.0 | 128.6 | 115.5 | 9.2 | 108.3 | 111.0 | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Multiples are an important financial analysis tool for the company Herbalife Nutrition Ltd., allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
USA
Russia
China
Canada
Brasil
